斯迪富维持MoonLake Immunotherapeutics(MLTX.US)买入评级,上调目标价至77美元 斯迪富分析师Alex Thompson CFA维持$MoonLake Immunotherapeutics(MLTX.US)$买入评级,并将目标价从69美元上调至77美元。根据TipRanks数据显示,该分析师近一年总胜率为48.8%,总平均回报率为5.4%。提示: TipRanks为独立第三方,提供金融分析师...
斯迪富維持MoonLake Immunotherapeutics(MLTX.US)買入評級,上調目標價至77美元 斯迪富分析師Alex Thompson CFA維持$MoonLake Immunotherapeutics(MLTX.US)$買入評級,並將目標價從69美元上調至77美元。根據TipRanks數據顯示,該分析師近一年總勝率為48.8%,總平均回報率為5.4%。提示: TipRanks為獨立第三方,提供金融分析師...
MLTX | Complete MoonLake Immunotherapeutics stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
MoonLake Immunotherapeutics options data by MarketWatch. View MLTX option chain data and pricing information for given maturity periods.
MLTXStock Latest News The FlyCapricor, Gilead, Kymera, Praxis among Oppenheimer’s top biotech picks for 2025 11d ago CAPR GILD Company Announcements MoonLake Immunotherapeutics Announces Board Changes and Incentives 12d ago 8K MLTX The Fly ...
Current Price $20.11 NASDAQ: AMPH Amphastar Pharmaceuticals Market Cap $2B Current Price $38.17 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. ...
MoonLake Immunotherapeutics Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arno...